Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
Clinical trial NCT05776875 · TERMINATED
Trial details
- NCT number
- NCT05776875
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2024-12-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.